Factor IX/factor IXa activating antibodies and antibody derivatives

US7033590B1 · kind B1 · utility

Assignee

• Baxter Aktiengesellschaft · AT

Inventors

• Friedrich Scheiflinger · Wien, AT
• Randolf Kerschbaumer · Klosterneuburg, AT
• Falko-Guenter Falkner · Orth an der Donau, AT
• Friedrich Dorner · Wien, AT
• Hans-Peter Schwarz · Wien, AT

Key dates

• Filing date: Sep 14, 2000
• Grant date: Apr 25, 2006
• Expiry date: Dec 20, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2039/505
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

An antibody or antibody derivative against factor IX/activated factor IX (FIXa) which increases the procoagulant activity of FIXa.